Abstract
Cellular signal transduction components are usually regulated not only on transcriptional or translational level, but also by posttranslational modifications. Among these, reversible phosphorylation represents the most abundant modification. In general, phosphorylation events are essential for regulating the activity of central signal transduction proteins, also including kinases itself. Members of the CK1 family can be found as central signal transduction proteins in numerous cellular pathways. Due to its wide variety of cellular functions the activity of CK1 family members has to be tightly regulated. We previously reported that PKA and Chk1 are able to phosphorylate CK1δ within its C-terminal regulatory domain, consequently resulting in altered CK1 kinase activity. In the present study, we show by several methods that protein kinase C α (PKCα) as well is able to phosphorylate CK1δ at its C-terminally located residues S328, T329, and S370. Furthermore, we analyze the functional consequences of PKCα-mediated phosphorylation on CK1δ kinase activity. Mutation of S328, T329, or S370 to alanine dramatically alters the kinetic parameters of CK1δ. By using the PKCα-specific inhibitor Go-6983 in a selected cell culture model, we finally show that the in vitro detected regulatory connection between PKCα and CK1δ is also relevant in the cellular context. Taken together, these data contribute to a deeper understanding of cellular signal transduction networks thereby helping to form a basis for the development of future therapeutic concepts.
Similar content being viewed by others
References
Anastassiadis T, Deacon SW, Devarajan K, Ma H, Peterson JR (2011) Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity. Nat Biotechnol 29(11):1039–1045. doi:10.1038/nbt.2017
Bischof J, Randoll SJ, Sussner N, Henne-Bruns D, Pinna LA, Knippschild U (2013) CK1delta kinase activity is modulated by Chk1-mediated phosphorylation. PLoS One 8(7):e68803. doi:10.1371/journal.pone.0068803
Cruciat CM (2014) Casein kinase 1 and Wnt/beta-catenin signaling. Curr Opin Cell Biol 31:46–55. doi:10.1016/j.ceb.2014.08.003
Daub H, Olsen JV, Bairlein M, Gnad F, Oppermann FS, Korner R, Greff Z, Keri G, Stemmann O, Mann M (2008) Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle. Mol Cell 31(3):438–448. doi:10.1016/j.molcel.2008.07.007
Dephoure N, Zhou C, Villen J, Beausoleil SA, Bakalarski CE, Elledge SJ, Gygi SP (2008) A quantitative atlas of mitotic phosphorylation. Proc Natl Acad Sci USA 105(31):10762–10767. doi:10.1073/pnas.0805139105
Dulla K, Daub H, Hornberger R, Nigg EA, Korner R (2010) Quantitative site-specific phosphorylation dynamics of human protein kinases during mitotic progression. Mol Cell Proteomics 9(6):1167–1181. doi:10.1074/mcp.M900335-MCP200
Dumaz N, Milne DM, Meek DW (1999) Protein kinase CK1 is a p53-threonine 18 kinase which requires prior phosphorylation of serine 15. FEBS Lett 463(3):312–316 (S0014-5793(99)01647-6 [pii])
Gao Y, Davies SP, Augustin M, Woodward A, Patel UA, Kovelman R, Harvey KJ (2013) A broad activity screen in support of a chemogenomic map for kinase signalling research and drug discovery. Biochem J 451(2):313–328. doi:10.1042/BJ20121418
Giamas G, Hirner H, Shoshiashvili L, Grothey A, Gessert S, Kuhl M, Henne-Bruns D, Vorgias CE, Knippschild U (2007) Phosphorylation of CK1delta: identification of Ser370 as the major phosphorylation site targeted by PKA in vitro and in vivo. Biochem J 406(3):389–398. doi:10.1042/BJ20070091
Graff JR, McNulty AM, Hanna KR, Konicek BW, Lynch RL, Bailey SN, Banks C, Capen A, Goode R, Lewis JE, Sams L, Huss KL, Campbell RM, Iversen PW, Neubauer BL, Brown TJ, Musib L, Geeganage S, Thornton D (2005) The protein kinase Cbeta-selective inhibitor, Enzastaurin (LY317615.HCl), suppresses signaling through the AKT pathway, induces apoptosis, and suppresses growth of human colon cancer and glioblastoma xenografts. Cancer Res 65(16):7462–7469. doi:10.1158/0008-5472.CAN-05-0071
Graves PR, Haas DW, Hagedorn CH, DePaoli-Roach AA, Roach PJ (1993) Molecular cloning, expression, and characterization of a 49-kilodalton casein kinase I isoform from rat testis. J Biol Chem 268(9):6394–6401
Gschwendt M, Dieterich S, Rennecke J, Kittstein W, Mueller HJ, Johannes FJ (1996) Inhibition of protein kinase C mu by various inhibitors. Differentiation from protein kinase c isoenzymes. FEBS Lett 392(2):77–80 (0014579396007855 [pii])
Knippschild U, Milne D, Campbell L, Meek D (1996) p53 N-terminus-targeted protein kinase activity is stimulated in response to wild type p53 and DNA damage. Oncogene 13(7):1387–1393
Knippschild U, Milne DM, Campbell LE, DeMaggio AJ, Christenson E, Hoekstra MF, Meek DW (1997) p53 is phosphorylated in vitro and in vivo by the delta and epsilon isoforms of casein kinase 1 and enhances the level of casein kinase 1 delta in response to topoisomerase-directed drugs. Oncogene 15(14):1727–1736. doi:10.1038/sj.onc.1201541
Knippschild U, Kruger M, Richter J, Xu P, Garcia-Reyes B, Peifer C, Halekotte J, Bakulev V, Bischof J (2014) The CK1 family: contribution to cellular stress response and its role in carcinogenesis. Front Oncol 4:96. doi:10.3389/fonc.2014.00096
Kulikov R, Winter M, Blattner C (2006) Binding of p53 to the central domain of Mdm2 is regulated by phosphorylation. J Biol Chem 281(39):28575–28583. doi:10.1074/jbc.M513311200
Mashhoon N, DeMaggio AJ, Tereshko V, Bergmeier SC, Egli M, Hoekstra MF, Kuret J (2000) Crystal structure of a conformation-selective casein kinase-1 inhibitor. J Biol Chem 275(26):20052–20060. doi:10.1074/jbc.M001713200
Morgan RT, Woods LK, Moore GE, Quinn LA, McGavran L, Gordon SG (1980) Human cell line (COLO 357) of metastatic pancreatic adenocarcinoma. Int J Cancer 25(5):591–598
Obenauer JC, Cantley LC, Yaffe MB (2003) Scansite 2.0: proteome-wide prediction of cell signaling interactions using short sequence motifs. Nucleic Acids Res 31(13):3635–3641
Perez DI, Gil C, Martinez A (2010) Protein kinases CK1 and CK2 as new targets for neurodegenerative diseases. Med Res Rev. doi:10.1002/med.20207
Reyland ME (2009) Protein kinase C isoforms: multi-functional regulators of cell life and death. Front Biosci (Landmark Ed) 14:2386–2399 (3385 [pii])
Richter J, Bischof J, Zaja M, Kohlhof H, Othersen O, Vitt D, Alscher V, Pospiech I, Garcia-Reyes B, Berg S, Leban J, Knippschild U (2014) Difluoro-dioxolo-benzoimidazol-benzamides as potent inhibitors of CK1delta and epsilon with nanomolar inhibitory activity on cancer cell proliferation. J Med Chem 57(19):7933–7946. doi:10.1021/jm500600b
Sakaguchi K, Saito S, Higashimoto Y, Roy S, Anderson CW, Appella E (2000) Damage-mediated phosphorylation of human p53 threonine 18 through a cascade mediated by a casein 1-like kinase. Effect on Mdm2 binding. J Biol Chem 275(13):9278–9283
Schittek B, Sinnberg T (2014) Biological functions of casein kinase 1 isoforms and putative roles in tumorigenesis. Mol Cancer 13(1):231. doi:10.1186/1476-4598-13-231
Toullec D, Pianetti P, Coste H, Bellevergue P, Grand-Perret T, Ajakane M, Baudet V, Boissin P, Boursier E, Loriolle F et al (1991) The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C. J Biol Chem 266(24):15771–15781
van der Geer P, Hunter T (1994) Phosphopeptide mapping and phosphoamino acid analysis by electrophoresis and chromatography on thin-layer cellulose plates. Electrophoresis 15(3–4):544–554
Venerando A, Ruzzene M, Pinna LA (2014) Casein kinase: the triple meaning of a misnomer. Biochem J 460(2):141–156. doi:10.1042/BJ20140178
Zhou H, Di Palma S, Preisinger C, Peng M, Polat AN, Heck AJ, Mohammed S (2013) Toward a comprehensive characterization of a human cancer cell phosphoproteome. J Proteome Res 12(1):260–271. doi:10.1021/pr300630k
Acknowledgments
The authors would like to thank Dr. Mirita Franz-Wachtel, Silke Wahl, and Johannes Madlung (Proteome Center Tübingen, University of Tübingen, Germany) for the performed mass spectrometric analyses as well as Annette Blatz and Julia Richter for excellent technical support. ZM gratefully acknowledges the China Scholarship Council (CSC) for his research grant at the University of Ulm. This work was supported by Deutsche Krebshilfe, Dr. Mildred Scheel Stiftung, awarded to Uwe Knippschild (108489).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Handling Editor: K. L. Bennett.
Z. Meng and J. Bischof equally contributed and P. Xu and U. Knippschild shared senior authorship.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Meng, Z., Bischof, J., Ianes, C. et al. CK1δ kinase activity is modulated by protein kinase C α (PKCα)-mediated site-specific phosphorylation. Amino Acids 48, 1185–1197 (2016). https://doi.org/10.1007/s00726-015-2154-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00726-015-2154-3